Concentration-dependent clearance of procainamide in normal subjects
- 1 April 1985
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 6 (2) , 159-165
- https://doi.org/10.1002/bdd.2510060207
Abstract
Four normal volunteers each received two intravenous doses of PA. The mean low dose was 3.30 mg kg−1 (infused over 20 minutes) while the mean high dose was 12.5 mg kg−1 (infused over 60 minutes). Blood samples were collected for 12 hours and urine was collected for 48 hours after each dose. PA concentrations were determined by both HPLC and fluorescent immunoassay methods. The reported concentrations and pharmacokinetic parameters are from the HPLC data unless otherwise indicated. The mean peak serum PA concentrations resulting from the low and high doses were 3.18 and 9.07 μg ml−1, respectively. Total PA clearance averaged 763 ml min−1 and 577 ml min−1 while renal clearance averaged 360 ml min−1 and 318 ml min−1 after the low and high doses, respectively. Concentration‐dependent decreases in nonrenal PA clearance ranged from 31 to 43 percent (p < 0.05) in the four subjects. Total clearance decreases ranged from 4.7 to 36 per cent (p < 0.05). Differences between doses in renal clearance, elimination rate constant, and volume of distribution were not statistically significant. This study demonstrates that the nonrenal and total clearances of PA are concentration‐dependent in normal subjects at therapeutic plasma PA concentrations and suggests that the total clearance changes are of sufficient magnitude to be clinically important.Keywords
This publication has 12 references indexed in Scilit:
- Complexation of Procainamide with DextroseJournal of Pharmaceutical Sciences, 1982
- Relationship between plasma levels of procainamide, suppression of premature ventricular complexes and prevention of recurrent ventricular tachycardia.Circulation, 1981
- Large dose procainamide therapy for ventricular tachyarrhythmiaThe American Journal of Cardiology, 1980
- Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotypeJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Safety and efficacy of procainamide infusionsThe American Journal of Cardiology, 1979
- Procainamide and N‐acetylprocainamide kinetics investigated simultaneously with stable isotope methodologyClinical Pharmacology & Therapeutics, 1977
- Relationship between the pharmacokinetics and pharmacodynamics of procainamideClinical Pharmacology & Therapeutics, 1976
- Elimination rate ofN-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in manJournal of Pharmacokinetics and Biopharmaceutics, 1975
- PHARMACOKINETICS OF PROCAINAMIDE IN MAN*Annals of the New York Academy of Sciences, 1971